Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients

Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients

A degradation product of APOE ε4-encoded apolipoprotein E protein targets mitochondria and inhibits cytochrome oxidase (COX), and autopsy brains from young adult APOE ε4 carriers show reduced COX activity. To further explore relationships between APOE alleles and COX, we measured platelet mitochondr...

Full description

Bibliographic Details
Main Authors:	Heather M. Wilkins, Scott J. Koppel, Rebecca Bothwell, Jonathan Mahnken, Jeffrey M. Burns, Russell H. Swerdlow
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Series:	Redox Biology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213231717302422

Similar Items

A systems view of the differences between APOE ε4 carriers and non-carriers in Alzheimer’s disease
by: Shan Jiang, et al.
Published: (2016-07-01)

Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
by: Yu Sun, et al.
Published: (2019-06-01)

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
by: Zokaei, N, et al.
Published: (2016)

Accelerated long-term forgetting in asymptomatic APOE ε4 carriers
by: Zimmermann, J, et al.
Published: (2018)

APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
by: Min Hou, et al.
Published: (2021-02-01)

Emerging Roles in the Biogenesis of Cytochrome c Oxidase for Members of the Mitochondrial Carrier Family
by: Oluwaseun B. Ogunbona, et al.
Published: (2019-01-01)

Association of Homocysteine Levels With Medial Temporal Lobe Atrophy Among Carriers and Non-carriers of APOE ε4 in MCI Subjects
by: Jun Ma, et al.
Published: (2022-04-01)

Differences in resting-state brain networks and gray matter between APOE ε2 and APOE ε4 carriers in non-dementia elderly
by: Zhiyuan Wang, et al.
Published: (2023-08-01)

CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers
by: Ahmad, S, et al.
Published: (2020)

Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease
by: Rebecca Kerestes, et al.
Published: (2015-10-01)

Superior short-term memory in APOE ε2 carriers across the age range
by: Zokaei, N, et al.
Published: (2020)

Short-term memory advantage for brief durations in human APOE ε4 carriers
by: Zokaei, N, et al.
Published: (2020)

Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score
by: Jarith L. Ebenau, et al.
Published: (2021-01-01)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
by: Yen Ying Lim, et al.
Published: (2021-01-01)

The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
by: Dongpeng Wu, et al.
Published: (2021-06-01)

Corrigendum: Differences in resting-state brain networks and gray matter between APOE ϵ2 and APOE ϵ4 carriers in non-dementia elderly
by: Zhiyuan Wang, et al.
Published: (2024-01-01)

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers
by: Fernanda Schäfer Hackenhaar, et al.
Published: (2021-07-01)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
by: Pascual Sánchez-Juan, et al.
Published: (2019-12-01)

Cognitive control and memory in healthy ApoE-ε4 carriers with a family history of Alzheimer’s disease.
by: Velichkovsky B.B., et al.
Published: (2015-03-01)

Novel Alzheimer’s disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers
by: Jong-Ho Park, et al.
Published: (2021-05-01)

Corrigendum: The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
by: Dongpeng Wu, et al.
Published: (2022-05-01)

Correction: Short leukocyte telomeres predict 25-year Alzheimer’s disease incidence in non-APOE ε4-carriers
by: Fernanda Schäfer Hackenhaar, et al.
Published: (2024-02-01)

Tract-specific differences in white matter microstructure between young adult APOE ε4 carriers and non-carriers: A replication and extension study
by: Rikki Lissaman, et al.
Published: (2022-12-01)

APOE ε4 Gene Carriers Demonstrate Reduced Retinal Capillary Densities in Asymptomatic Older Adults
by: Ziyi Zhang, et al.
Published: (2023-08-01)

Retinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriers
by: Fanny M. Elahi, et al.
Published: (2021-01-01)

Increased apolipoprotein E and decreased TNF‐α in the cerebrospinal fluid of nondemented APOE‐ε4 carriers
by: Daimei Sasayama, et al.
Published: (2020-06-01)

Functional co-activation of the default mode network in APOE ε4-carriers: A replication study
by: Lara J. Mentink, et al.
Published: (2021-10-01)

Feeding Cells with a Novel “Trojan” Carrier: Citrate Nanoparticles
by: Natchanon Rimsueb, et al.
Published: (2020-03-01)

Platelet-derived growth factor-BB and white matter hyperintensity burden in APOE4 carriers
by: Arunima Kapoor, et al.
Published: (2022-01-01)

The <i>APOE</i> ε4 Allele Affects Cognitive Functions Differently in Carriers of <i>APP</i> Mutations Compared to Carriers of <i>PSEN1</i> Mutations in Autosomal-Dominant Alzheimer’s Disease
by: Ove Almkvist, et al.
Published: (2021-12-01)

APOEε4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial
by: Yanfang Zeng, et al.
Published: (2024-03-01)

The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond
by: Rami Mosaoa, et al.
Published: (2021-01-01)

Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
by: de Souza Aparecido R, et al.
Published: (2011-03-01)

Association Between Hippocampus, Thalamus, and Caudate in Mild Cognitive Impairment APOEε4 Carriers: A Structural Covariance MRI Study
by: Fabiana Novellino, et al.
Published: (2019-12-01)

Conjugated linoleic acid and hepatic lipogenesis in mouse: role of the mitochondrial citrate carrier
by: Alessandra Ferramosca, et al.
Published: (2006-09-01)

Association between ApoE ε4 Carrier Status and Cardiovascular Risk Factors on Mild Cognitive Impairment among Mexican Older Adults
by: Sara G. Aguilar-Navarro, et al.
Published: (2021-01-01)

Prevention of cognitive decline in subjective cognitive decline APOE ε4 carriers after EGCG and a multimodal intervention (PENSA): Study design
by: Laura Forcano, et al.
Published: (2021-01-01)

Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment
by: Tammy T. Tran, et al.
Published: (2017-01-01)

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
by: Dovilė Pocevičiūtė, et al.
Published: (2022-08-01)

Allosteric role of the citrate synthase homology domain of ATP citrate lyase
by: Xuepeng Wei, et al.
Published: (2023-04-01)